---
layout: post
title: "CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS THERAPY UNTUK PENYAKIT AUTOIMUN"
author: "Roihan Mohamad Iqbal, Anindya Intan Ardanari, Muthia Fahiratunnisa Amany, Dyah Ayu Mira Oktarina"
description: "Pendahuluan Pemphigus vulgaris PV merupakan penyakit autoimun bolus kronis yang jarang ditemukan namun dapat berpotensi mengancam nyawa melalui adhesi protein autoant"
categories: essential
canonical_url: https://jurnal.harianregional.com/essential/id-53784
comments: true
citation_abstract_html_url: "https://jurnal.harianregional.com/essential/id-53784"
citation_pdf_url: "https://jurnal.harianregional.com/essential/full-53784"
tags:

---

## Authors:
Roihan Mohamad Iqbal, Anindya Intan Ardanari, Muthia Fahiratunnisa Amany, Dyah Ayu Mira Oktarina

## Abstract:
"Pendahuluan: Pemphigus vulgaris (PV) merupakan penyakit autoimun bolus kronis yang jarang ditemukan namun dapat berpotensi mengancam nyawa melalui adhesi protein autoantibodi desmoglein 3. Pengobatan PV yang paling sering digunakan saat ini adalah imunosupresan yang memiliki efek samping seperti peningkatan respon imun dan kemudian dapat kambuh kembali atau terjadi relapse. Oleh karena itu, dibutuhkan inovasi baru dalam pengobatan penyakit autoimun yang lebih spesifik dan dapat mencegah relaps pada jangka waktu yang lama.Tujuan penilitian ini adalah untuk melihat pengobatan terbaru yaitu penggunaan CAR T-cell dalam PV.Pembahasan : Pada pasien PV akan ditemukan adanya autoantibodi yang melawan desmoglein 3 (?Dsg3). ?Dsg3 sering ditemukan pada membran mukosa dan mucocutaneous. Aktivasi berlebih dari sel CD4+ Th2 menyebabkan adanya autoantibodi. CAR T-cell merupakan hasil dari rekayasi sel T yang dibantu vektor yang membawa reseptor chimera sesuai dengan yang ditargetkan . Pengobatan menggunakan CAR T-cell semakin menjanjikan setelah persetujuan FDA terhadap dua obat untuk kanker hematologi. Peneliti tertarik dalam mengembangkan CAR T-cell sebagai pengobatan penyakit autoimun. Hasil in vitro dari CAAR T-cell (modifikasi CAR T-cell) menunjukkan aktivitas sitotoksik sensitif melawan ?Dsg3 BCR. Hasil in vivo menunjukkan potensi terhadap eliminasi spesifik dari B cells Dsg3 berdasarkan serum dan sukses dalam mempertahankan intergritas epidermal pada tikus.Kesimpulan : CAR T-cell menunjukkan potensi sebagai pilihan terapi PV di masa depan. Akan tetapi, pengembangan dan penelitian lebih lanjut terhadap penggunaan CAR T-cell diperlukan untuk terapi PV sehingga dapat dihasilkan pilih pengobatan yang spesifik dengan efek samping minimum bagi pasien."

### Keywords
*Keyword Not Available*

### Downloads:
Download data is not yet available.

{% include adsense.html %}
## References
- 1. Zeina B. Pemphigus Vulgaris: Practice Essentials, Background, Pathophysiology [Internet]. e-Medicine Medscape. 2018 [cited 2 July 2019]. Available from: https://emedicine.medscape.com/article/1064187-overview#a1
- 2. Ellebrecht C, Bhoj V, Nace A, Choi E, Mao X, Cho M et al. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. Science. 2016;353(6295):179-184.
- 3. Cholera M, Chainani-Wu N. Management of Pemphigus Vulgaris. Advances in Therapy. 2016;33(6):910-958.
- 4. Porro A, Hans Filho G, Santi C. Consensus on the treatment of autoimmune bullous dermatoses: pemphigus vulgaris and pemphigus foliaceus - Brazilian Society of Dermatology. Anais Brasileiros de Dermatologia. 2019;94(2 suppl 1):20-32.
- 5. Han X, Wang Y, Han W. Chimeric antigen receptor modified T-cells for cancer treatment. Chronic Diseases and Translational Medicine. 2018;4(4):225-243.
- 6. Wilkins O, Keeler A, Flotte T. CAR T-Cell Therapy: Progress and Prospects. Human Gene Therapy Methods. 2017;28(2):61-66.
- 7. Kanwar AJ, Vinay K. Rituximab in pemphigus. Indian J Dermatol Venereol Leprol 2012;78:671-6
- 8. Dai H, Wang Y, Lu X, Han W. Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy. JNCI: Journal of the National Cancer Institute. 2016;108(7).
- 9. Madala J, Bashamalla R, Kumar M. Current concepts of pemphigus with a deep insight into its molecular aspects. Journal of Oral and Maxillofacial Pathology. 2017;21(2):260
- 10. Dimarco C. Pemphigus : Pathogenesis to Treatment. Rhode Island Medical Journal [Internet]. 2016 [cited 30 June 2019];:28-31. Available from: http://www. rimed.org/rimedicaljournal/2016/12/2016-12-28-autoimmune-dimarco.pdf
- 11. Hammers C, Stanley J. Mechanisms of Disease: Pemphigus and Bullous Pemphigoid. Annual Review of Pathology: Mechanisms of Disease. 2016;11(1):175-197.
- 12. Takahashi H, Kouno M, Nagao K, Wada N, Hata T, Nishimoto S et al. Desmoglein 3–specific CD4+ T cells induce pemphigus vulgaris and interface dermatitis in mice. Journal of Clinical Investigation. 2011;121(9):3677-3688.
- 13. Español-Rego M, Marzal B, Juan M, Castella M, Boronat A. Future of Chimeric Antigen Receptors (Cars): Could it Drive Solutions Beyond Cancer? Examples in Autoimmune Diseases [Internet]. Pdfs.semanticscholar.org. 2019
- [cited 2 July 2019]. Available from: https://pdfs.semanticscholar.org /48ab/192bdef6328fb84f861546e42ed20a3c204a.pdf
- 14. Miliotou A, Papadopoulou L. CAR T-cell Therapy: A New Era in Cancer Immunotherapy. Current Pharmaceutical Biotechnology. 2018;19(1):5-18.
- 15. Watanabe K, Kuramitsu S, Posey A, June C. Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology. Frontiers in Immunology. 2018;9.
- 16. Tahir A. Is Chimeric Antigen Receptor T-cell Therapy the Future of Autoimmunity Management?. Cureus. 2018
- 17. Ellebrecht C, Payne A. Setting the target for pemphigus vulgaris therapy. JCI Insight. 2017;2(5).
- 18. Kotredes K, Gamero A. Interferons as Inducers of Apoptosis in Malignant Cells. Journal of Interferon and Cytokine Research [Internet]. 2013 [cited 2 July 2019];33(4):162-170. Available from: https://www. ncbi.nlm.nih.gov/pmc/articles/PMC3624694/
- 19. Hofrichter M, Dworschak J, Emtenani S, Langenhan J, Weiß F, Komorowski L et al. Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice. Frontiers in Immunology. 2018;9.
- 20. Zhang AH, Yoon J, Kim YC, and Scott DW. Targeting Antigen-Specific B Cells using Antigen-Expressing Transduced Regulatory T Cells. J. Immunol 18 July 2018
- 21. Kim M, Kim D, Suh S, Park Z, Choi M, Oh Y. Current status and regulatory perspective of chimeric antigen receptor-modified T cell therapeutics. Archives of Pharmacal Research. 2016;39(4):437-452.
- 22. Morgan R, Yang J, Kitano M, Dudley M, Laurencot C, Rosenberg S. Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2. Molecular Therapy. 2010;18(4):843-851.
- 23. Kalos M, Levine B, Porter D, Katz S, Grupp S, Bagg A et al. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia. Science Translational Medicine. 2011;3(95):95ra73-95ra73.
- 24. Xu D, Jin G, Chai D, Zhou X, Gu W, Chong Y et al. The development of CAR design for tumor CAR-T cell therapy. Oncotarget. 2018;9(17).
- 25. Kalantari-Dehaghi M, Anhalt G, Camilleri M, Chernyavsky A, Chun S, Felgner P et al. Pemphigus Vulgaris Autoantibody Profiling by Proteomic Technique. PLoS ONE. 2013;8(3):

### PDF:

{% include adsense1.html %}

<https://jurnal.harianregional.com/essential/full-53784>

{% include adsense2.html %}

### Published
2020-08-01

### How To Cite
IQBAL, Roihan Mohamad et al.  CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS THERAPY UNTUK PENYAKIT AUTOIMUN.Essential: Essence of Scientific Medical Journal, [S.l.], v. 18, n. 1, p. 6-11, aug. 2020. ISSN 2655-6472. Available at: <https://jurnal.harianregional.com/essential/id-53784>. Date accessed: {{ site.time | date: "%d %b. %Y" }}.

## Citation Format
ABNT, APA, BibTeX, CBE, EndNote - EndNote format (Macintosh & Windows), MLA, ProCite - RIS format (Macintosh & Windows), RefWorks, Reference Manager - RIS format (Windows only), Turabian

### Issue
Vol 18 No 1 (2020): Volume 18 No. 1 (Januari - Juni 2020) Essential: Essence of Scientific Medical Journal

### Section 
**Articles**

### Copyright 
{% include inarticle.html %}
<a href="http://creativecommons.org/licenses/by/4.0/" rel="license"><img src="https://i.creativecommons.org/l/by/4.0/88x31.png" alt="Creative Commons License" /></a>
This work is licensed under a <a href="http://creativecommons.org/licenses/by/4.0/" rel="nofollow">Creative Commons Attribution 4.0 International License</a>

{% include multiplex.html %}
